Skip to content
OpenCapital
Get started

Staar Surgical STAA Enterprise value

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$21.45B-5.6%
IAR
Integra LifeSciencesIART
$2.47B-26.7%
ITG
Integer HoldingsITGR
$4.4B-19.6%
Glaukos logo
GlaukosGKOS
$6.25B+12.5%
HRO
HarrowHROW
$1.53B+13.8%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+47.4%
P/S5×+1.5×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Calculated from Staar Surgical’s reported figures.

$1.3Bmarket cap+$37.3Mtotal debt−$131.9Mcash and equivalents=$1.21B

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's enterprise value?
Staar Surgical (STAA) reported enterprise value of $1.21B in Q1 2026.
How has Staar Surgical's enterprise value changed year-over-year?
Staar Surgical's enterprise value increased by 61.6% year-over-year, from $749.09M to $1.21B.
What is the long-term trend for Staar Surgical's enterprise value?
Over 5 years (2020 to 2025), Staar Surgical's enterprise value has grown at a -29.6% compound annual growth rate (CAGR), from $4.74B to $820.69M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.